Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment

The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and cellular composition of the tumor is of particular interest. Mesenchymal stem cells (MSCs) are a major group of cells in the tumor tissue and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinical and experimental medicine Ročník 21; číslo 2; s. 205 - 213
Hlavní autoři: Arab, Samaneh, Alizadeh, Akram, Asgharzade, Samira
Médium: Journal Article
Jazyk:angličtina
Vydáno: Cham Springer International Publishing 01.05.2021
Springer Nature B.V
Témata:
Adenosine
Apoptosis
Cancer
Cancer therapies
CD4 antigen
Cell activation
Cell proliferation
Hematology
Immune system
Immunological tolerance
Inflammation
Internal Medicine
Lymphocytes T
Medicine
Medicine & Public Health
Mesenchymal stem cells
Microenvironments
Oncology
PD-1 protein
PD-L1 protein
Phenotypes
Prostaglandin E2
Review Article
Stem cells
Tryptophan 2,3-dioxygenase
Adenosine
CD73
Cancer
Mesenchymal stem cells
ISSN:1591-8890, 1591-9528, 1591-9528
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and cellular composition of the tumor is of particular interest. Mesenchymal stem cells (MSCs) are a major group of cells in the tumor tissue and play a critical role in tumor growth and development. Investigating the mechanisms by which MSCs influence tumor growth and progression is very useful in establishing new therapeutic approaches. MSCs have some immunological capacities, including anti-inflammatory, immune-regulatory, and immune-suppressive abilities, which help the tumor growth in the inflammatory condition. They can suppress the proliferation and activation of CD4 + T cells and direct them toward the regulatory phenotype through the release of some factors such as indoleamine 2,3-dioxygenase, prostaglandin E2, and HO-1, PD-1 ligands (PD-L1 and PD-L2) and promote tolerance and apoptosis. Besides, these cells are able to produce adenosine. Adenosine has a key role in controlling the immune system by signaling through receptors located on the surface of immune cells. It plays a very essential role in tumor growth and progression. In the present review, we investigate and introduce adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.
AbstractList The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and cellular composition of the tumor is of particular interest. Mesenchymal stem cells (MSCs) are a major group of cells in the tumor tissue and play a critical role in tumor growth and development. Investigating the mechanisms by which MSCs influence tumor growth and progression is very useful in establishing new therapeutic approaches. MSCs have some immunological capacities, including anti-inflammatory, immune-regulatory, and immune-suppressive abilities, which help the tumor growth in the inflammatory condition. They can suppress the proliferation and activation of CD4 + T cells and direct them toward the regulatory phenotype through the release of some factors such as indoleamine 2,3-dioxygenase, prostaglandin E2, and HO-1, PD-1 ligands (PD-L1 and PD-L2) and promote tolerance and apoptosis. Besides, these cells are able to produce adenosine. Adenosine has a key role in controlling the immune system by signaling through receptors located on the surface of immune cells. It plays a very essential role in tumor growth and progression. In the present review, we investigate and introduce adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and cellular composition of the tumor is of particular interest. Mesenchymal stem cells (MSCs) are a major group of cells in the tumor tissue and play a critical role in tumor growth and development. Investigating the mechanisms by which MSCs influence tumor growth and progression is very useful in establishing new therapeutic approaches. MSCs have some immunological capacities, including anti-inflammatory, immune-regulatory, and immune-suppressive abilities, which help the tumor growth in the inflammatory condition. They can suppress the proliferation and activation of CD4 + T cells and direct them toward the regulatory phenotype through the release of some factors such as indoleamine 2,3-dioxygenase, prostaglandin E2, and HO-1, PD-1 ligands (PD-L1 and PD-L2) and promote tolerance and apoptosis. Besides, these cells are able to produce adenosine. Adenosine has a key role in controlling the immune system by signaling through receptors located on the surface of immune cells. It plays a very essential role in tumor growth and progression. In the present review, we investigate and introduce adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.
The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and cellular composition of the tumor is of particular interest. Mesenchymal stem cells (MSCs) are a major group of cells in the tumor tissue and play a critical role in tumor growth and development. Investigating the mechanisms by which MSCs influence tumor growth and progression is very useful in establishing new therapeutic approaches. MSCs have some immunological capacities, including anti-inflammatory, immune-regulatory, and immune-suppressive abilities, which help the tumor growth in the inflammatory condition. They can suppress the proliferation and activation of CD4 + T cells and direct them toward the regulatory phenotype through the release of some factors such as indoleamine 2,3-dioxygenase, prostaglandin E2, and HO-1, PD-1 ligands (PD-L1 and PD-L2) and promote tolerance and apoptosis. Besides, these cells are able to produce adenosine. Adenosine has a key role in controlling the immune system by signaling through receptors located on the surface of immune cells. It plays a very essential role in tumor growth and progression. In the present review, we investigate and introduce adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.
The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and cellular composition of the tumor is of particular interest. Mesenchymal stem cells (MSCs) are a major group of cells in the tumor tissue and play a critical role in tumor growth and development. Investigating the mechanisms by which MSCs influence tumor growth and progression is very useful in establishing new therapeutic approaches. MSCs have some immunological capacities, including anti-inflammatory, immune-regulatory, and immune-suppressive abilities, which help the tumor growth in the inflammatory condition. They can suppress the proliferation and activation of CD4 + T cells and direct them toward the regulatory phenotype through the release of some factors such as indoleamine 2,3-dioxygenase, prostaglandin E2, and HO-1, PD-1 ligands (PD-L1 and PD-L2) and promote tolerance and apoptosis. Besides, these cells are able to produce adenosine. Adenosine has a key role in controlling the immune system by signaling through receptors located on the surface of immune cells. It plays a very essential role in tumor growth and progression. In the present review, we investigate and introduce adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.
Author Alizadeh, Akram
Arab, Samaneh
Asgharzade, Samira
Author_xml – sequence: 1
  givenname: Samaneh
  surname: Arab
  fullname: Arab, Samaneh
  organization: Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Department of Tissue Engineering and Applied Cell Sciences, School of Medicine, Semnan University of Medical Sciences
– sequence: 2
  givenname: Akram
  surname: Alizadeh
  fullname: Alizadeh, Akram
  organization: Department of Tissue Engineering and Applied Cell Sciences, School of Medicine, Semnan University of Medical Sciences
– sequence: 3
  givenname: Samira
  orcidid: 0000-0003-1334-5625
  surname: Asgharzade
  fullname: Asgharzade, Samira
  email: Asgharzade2336@gmail.com
  organization: Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33484380$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1rHSEUhqWkNJ9_oIsidNONjV8z6rKEtgkEuknX4tUzt4YZvVVnkX9fb-5tC1kEDh7hPK_nxfccnaScAKH3jH5mlKrryigXmlBOCaWjksS8QWdsMIyYgeuT411rQ0_Rea2PlLJBC_oOnQohtRSanqHwsC65kAI1BkgNu37mGhOQXclh9TFt8QIVkv_1tLgZ1wYL9jDPFbteeJdbl8U-aa5soeEpF-xd8lBwK-Da0seX6O3k5gpXx36Bfn77-nBzS-5_fL-7-XJPvFBDI8JLJ1yYmHcTaMWU00aBkcb4MXjHPOds3OjNIKkKnkKY_MSkHqXjU3DKiwv06fBu9_57hdrsEuverEuQ12q51FSIUQvT0Y8v0Me8ltTdWT4wqRjTknXqw5FaNwsEuytxceXJ_v2_DvAD4EuutcD0D2HU7kOyh5BsD8k-h2T3u_ULkY_NtZhTKy7Or0vFQVr7nrSF8t_2K6o_30qnNg
CitedBy_id crossref_primary_10_3390_ijms26157594
crossref_primary_10_1007_s12031_025_02307_w
crossref_primary_10_3389_fimmu_2022_957233
crossref_primary_10_1007_s12094_021_02732_4
crossref_primary_10_1080_13543784_2022_2078191
crossref_primary_10_1186_s12938_024_01320_1
crossref_primary_10_3389_fcell_2022_893709
crossref_primary_10_1007_s10565_021_09658_1
crossref_primary_10_1002_iub_2905
crossref_primary_10_1007_s11538_023_01247_z
crossref_primary_10_3390_ijms25063347
Cites_doi 10.1158/1538-7445.AM2019-5200
10.1155/2017/5173732
10.1155/2019/7219297
10.1007/s12010-017-2684-0
10.1093/carcin/bgz083
10.1089/scd.2018.0183
10.1038/s41388-020-1230-7
10.1111/cas.13334
10.1038/s41571-018-0007-1
10.1016/j.stemcr.2018.02.009
10.1186/s12885-017-3892-2
10.1080/2162402X.2017.1320011
10.1038/onc.2013.387
10.1152/japplphysiol.00350.2015
10.1016/j.molmed.2013.03.005
10.1007/s13277-015-4732-0
10.1073/pnas.0908801107
10.1158/0008-5472.CAN-17-2158
10.1073/pnas.1718197115
10.3389/fimmu.2019.01729
10.1089/scd.2015.0227
10.3390/cells8080886
10.1016/j.scr.2011.04.001
10.1038/nrc2067
10.1002/jbmr.424
10.4110/in.2019.19.e23
10.1186/s13046-018-1018-6
10.1186/scrt484
10.1038/nrclinonc.2010.196
10.1158/2159-8290.CD-14-0341
10.1159/000323973
10.1016/j.ejphar.2020.173509
10.1038/nrc822
10.1038/nature06188
10.1182/blood-2010-12-324038
10.1159/000479998
10.1002/stem.2509
10.3390/vaccines4040041
10.1177/1010428317695021
10.1016/j.celrep.2019.04.091
10.1038/s41568-018-0056-x
10.3727/096368910X546553
10.1038/nrd.2016.193
10.1186/s12943-017-0597-8
10.1002/pros.23738
10.1080/15384101.2018.1450029
10.1186/s13046-014-0119-0
10.1074/jbc.RA118.006889
10.15171/apb.2019.063
10.1007/s13577-020-00339-5
10.1007/s10616-017-0134-z
10.1002/stem.1432
10.1007/s00262-016-1879-5
10.1002/jcb.27091
10.1158/0008-5472.CAN-10-1544
10.1080/00016489.2017.1378436
10.1186/s13287-019-1220-2
10.1172/JCI39104
10.1186/s12929-017-0402-4
10.1002/(SICI)1097-0215(19961115)68:4<493::AID-IJC15>3.0.CO;2-6
10.1152/physrev.00049.2017
ContentType Journal Article
Copyright Springer Nature Switzerland AG 2021
Springer Nature Switzerland AG 2021.
Copyright_xml – notice: Springer Nature Switzerland AG 2021
– notice: Springer Nature Switzerland AG 2021.
DBID AAYXX
CITATION
NPM
7T5
7TK
H94
K9.
7X8
DOI 10.1007/s10238-020-00674-9
DatabaseName CrossRef
PubMed
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1591-9528
EndPage 213
ExternalDocumentID 33484380
10_1007_s10238_020_00674_9
Genre Journal Article
Review
GroupedDBID ---
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
203
29B
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5VS
67Z
6NX
7X7
875
88E
8AO
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAHNG
AAIAL
AAJKR
AAJSJ
AAKKN
AANXM
AANZL
AARHV
AARTL
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABEEZ
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMOR
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACACY
ACBXY
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACULB
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGXO
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
C24
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GUQSH
GXS
H13
HF~
HG5
HG6
HLICF
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KOV
KPH
LAS
LLZTM
M1P
M2O
M4Y
MA-
MK0
N2Q
N9A
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
Q2X
QOR
QOS
R89
R9I
RIG
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z87
ZMTXR
ZOVNA
AAFWJ
AASML
AAYXX
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFFHD
AFHIU
AGQPQ
AHPBZ
AHWEU
AIXLP
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
NPM
7T5
7TK
H94
K9.
7X8
ID FETCH-LOGICAL-c375t-3c4a3adf1cafe8717a897e9499c6dca1c2216b8b5407dc0edfcf14864a2fda7c3
IEDL.DBID RSV
ISICitedReferencesCount 12
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000610477500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1591-8890
1591-9528
IngestDate Thu Oct 02 10:49:36 EDT 2025
Mon Oct 06 18:18:46 EDT 2025
Wed Feb 19 02:28:54 EST 2025
Tue Nov 18 22:21:56 EST 2025
Sat Nov 29 04:05:00 EST 2025
Fri Feb 21 02:48:32 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Adenosine
CD73
Cancer
Mesenchymal stem cells
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-3c4a3adf1cafe8717a897e9499c6dca1c2216b8b5407dc0edfcf14864a2fda7c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-1334-5625
PMID 33484380
PQID 2514711841
PQPubID 43686
PageCount 9
ParticipantIDs proquest_miscellaneous_2480336839
proquest_journals_2514711841
pubmed_primary_33484380
crossref_primary_10_1007_s10238_020_00674_9
crossref_citationtrail_10_1007_s10238_020_00674_9
springer_journals_10_1007_s10238_020_00674_9
PublicationCentury 2000
PublicationDate 2021-05-01
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Italy
– name: Milano
PublicationTitle Clinical and experimental medicine
PublicationTitleAbbrev Clin Exp Med
PublicationTitleAlternate Clin Exp Med
PublicationYear 2021
Publisher Springer International Publishing
Springer Nature B.V
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
References Xie (CR63) 2019; 38
Katsuta (CR36) 2019; 79
Antonioli (CR44) 2013; 19
Valkenburg, de Groot, Pienta (CR30) 2018; 15
Poggi, Giuliani (CR5) 2016; 4
Lupia (CR39) 2018; 10
Lytle, Barber, Reya (CR26) 2018; 18
Borea (CR35) 2018; 98
Albini, Sporn (CR1) 2007; 7
Stone (CR41) 2019; 294
Kalluri, Weinberg (CR23) 2009; 119
Ren (CR14) 2014; 33
Amini-Farsani (CR50) 2018; 70
Guerrouahen (CR4) 2019
Young (CR10) 2014; 4
Thiery (CR22) 2002; 2
Ávila-Ibarra (CR57) 2019; 28
Han (CR3) 2019; 8
Davies (CR8) 2017; 35
Ujházy (CR46) 1996; 68
Samanta (CR58) 2018; 115
Ridge, Sullivan, Glynn (CR15) 2017; 16
Mandapathil (CR38) 2018; 138
Shi (CR13) 2017; 16
Jadidi-Niaragh (CR52) 2016; 37
Schneider (CR45) 2019; 10
Valeta-Magara (CR25) 2019; 79
Yagi, Kitagawa (CR64) 2013; 4
Mougiakakos (CR7) 2011; 117
Tang (CR24) 2020; 41
Kheshtchin (CR43) 2016; 65
Zhang (CR9) 2010; 70
Takebe (CR27) 2011; 8
Yin (CR31) 2020; 33
Perrot (CR33) 2019; 27
Jiang (CR40) 2018; 18
Arab, Hadjati (CR51) 2019; 19
Rohban, Pieber (CR2) 2017
Sajadpoor (CR47) 2018; 185
Qi (CR20) 2017; 42
Saldanha-Araujo (CR55) 2011; 7
Kansy (CR18) 2014; 5
Liu, Xia (CR34) 2015; 119
Gharibi (CR53) 2011; 26
Wang (CR21) 2019; 10
Melief (CR6) 2013; 31
Li (CR17) 2015; 34
Ayob, Ramasamy (CR59) 2018; 25
Tian (CR65) 2010; 26
Chen (CR56) 2016; 25
Stagg (CR32) 2010; 107
Arab (CR11) 2017; 39
Khayami (CR48) 2018; 119
Sattler (CR54) 2011; 20
Xu (CR62) 1864; 11
Rahmatizadeh (CR28) 2019; 9
Krueger (CR16) 2019; 79
Ono (CR37) 2018; 15
Karnoub (CR12) 2007; 449
Lee, Hong (CR29) 2017; 108
Yoe (CR60) 2020; 39
Shahar (CR19) 2017; 19
Li (CR42) 2017; 6
Asgharzade (CR49) 2020; 886
Simón-Carrasco (CR61) 2018; 17
J Qi (674_CR20) 2017; 42
M Mandapathil (674_CR38) 2018; 138
A Young (674_CR10) 2014; 4
T Jiang (674_CR40) 2018; 18
SM Ridge (674_CR15) 2017; 16
N Kheshtchin (674_CR43) 2016; 65
I Perrot (674_CR33) 2019; 27
PA Borea (674_CR35) 2018; 98
M Lupia (674_CR39) 2018; 10
S Arab (674_CR51) 2019; 19
H Tang (674_CR24) 2020; 41
R Rohban (674_CR2) 2017
C Sattler (674_CR54) 2011; 20
AE Karnoub (674_CR12) 2007; 449
A Albini (674_CR1) 2007; 7
R Khayami (674_CR48) 2018; 119
LC Davies (674_CR8) 2017; 35
G Ren (674_CR14) 2014; 33
P Ujházy (674_CR46) 1996; 68
N Takebe (674_CR27) 2011; 8
L Simón-Carrasco (674_CR61) 2018; 17
S Asgharzade (674_CR49) 2020; 886
Y Shi (674_CR13) 2017; 16
Z Sajadpoor (674_CR47) 2018; 185
H Liu (674_CR34) 2015; 119
AZ Ayob (674_CR59) 2018; 25
W Li (674_CR17) 2015; 34
F Rahmatizadeh (674_CR28) 2019; 9
J Yoe (674_CR60) 2020; 39
Y Han (674_CR3) 2019; 8
C Xie (674_CR63) 2019; 38
B Zhang (674_CR9) 2010; 70
NK Lytle (674_CR26) 2018; 18
TE Krueger (674_CR16) 2019; 79
D Mougiakakos (674_CR7) 2011; 117
JK Stone (674_CR41) 2019; 294
JP Thiery (674_CR22) 2002; 2
D Samanta (674_CR58) 2018; 115
BA Kansy (674_CR18) 2014; 5
K Ono (674_CR37) 2018; 15
SM Melief (674_CR6) 2013; 31
LR Ávila-Ibarra (674_CR57) 2019; 28
R Kalluri (674_CR23) 2009; 119
M Xu (674_CR62) 1864; 11
J Stagg (674_CR32) 2010; 107
X Chen (674_CR56) 2016; 25
A Poggi (674_CR5) 2016; 4
K Tian (674_CR65) 2010; 26
S Wang (674_CR21) 2019; 10
J Li (674_CR42) 2017; 6
Z Amini-Farsani (674_CR50) 2018; 70
L Yin (674_CR31) 2020; 33
A Valeta-Magara (674_CR25) 2019; 79
E Schneider (674_CR45) 2019; 10
E Katsuta (674_CR36) 2019; 79
S Arab (674_CR11) 2017; 39
T Shahar (674_CR19) 2017; 19
BS Guerrouahen (674_CR4) 2019
HY Lee (674_CR29) 2017; 108
KC Valkenburg (674_CR30) 2018; 15
B Gharibi (674_CR53) 2011; 26
F Jadidi-Niaragh (674_CR52) 2016; 37
H Yagi (674_CR64) 2013; 4
F Saldanha-Araujo (674_CR55) 2011; 7
L Antonioli (674_CR44) 2013; 19
References_xml – volume: 79
  start-page: 5200
  issue: 13 Supplement
  year: 2019
  ident: CR36
  article-title: High CD73 expression, regulated by estrogen signaling, associates with cancer aggressiveness in estrogen receptor (+) breast cancer
  publication-title: Cancer Res.
  doi: 10.1158/1538-7445.AM2019-5200
– volume: 10
  start-page: 1729
  year: 2019
  ident: CR45
  article-title: Generation and function of non-cell-bound CD73 in inflammation
  publication-title: Front Immunol
– volume: 185
  start-page: 1132
  issue: 4
  year: 2018
  end-page: 1144
  ident: CR47
  article-title: Valproic acid promotes apoptosis and cisplatin sensitivity through downregulation of H19 noncoding RNA in ovarian A2780 cells
  publication-title: Appl Biochem Biotechnol
– volume: 25
  start-page: 337
  issue: 4
  year: 2016
  end-page: 346
  ident: CR56
  article-title: CD73 pathway contributes to the immunosuppressive ability of mesenchymal stem cells in intraocular autoimmune responses
  publication-title: Stem Cells Dev
– volume: 4
  start-page: 41
  issue: 4
  year: 2016
  ident: CR5
  article-title: Mesenchymal stromal cells can regulate the immune response in the tumor microenvironment
  publication-title: Vaccines
– volume: 8
  start-page: 97
  issue: 2
  year: 2011
  ident: CR27
  article-title: Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
  publication-title: Nat Rev Clin oncol
– volume: 6
  start-page: e1320011
  issue: 6
  year: 2017
  ident: CR42
  article-title: CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
  publication-title: Oncoimmunology
– volume: 28
  start-page: 477
  issue: 7
  year: 2019
  end-page: 488
  ident: CR57
  article-title: Mesenchymal stromal cells derived from normal cervix and cervical cancer tumors increase CD73 expression in cervical cancer cells through TGF-β1 production
  publication-title: Stem Cells Dev
– volume: 79
  start-page: 320
  issue: 3
  year: 2019
  end-page: 330
  ident: CR16
  article-title: Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
  publication-title: Prostate
– volume: 26
  start-page: 799
  issue: 6
  year: 2010
  end-page: 808
  ident: CR65
  article-title: p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells
  publication-title: Cell Physiol Biochem
– volume: 119
  start-page: 1173
  issue: 10
  year: 2015
  end-page: 1182
  ident: CR34
  article-title: Beneficial and detrimental role of adenosine signaling in diseases and therapy
  publication-title: J Appl Physiol
– volume: 7
  start-page: 66
  issue: 1
  year: 2011
  end-page: 74
  ident: CR55
  article-title: Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes
  publication-title: Stem Cell Res
– volume: 108
  start-page: 1939
  issue: 10
  year: 2017
  end-page: 1946
  ident: CR29
  article-title: Double-edged sword of mesenchymal stem cells: cancer-promoting versus therapeutic potential
  publication-title: Cancer Sci
– volume: 119
  start-page: 7905
  issue: 10
  year: 2018
  end-page: 7912
  ident: CR48
  article-title: Role of adenosine signaling in the pathogenesis of head and neck cancer
  publication-title: J Cell Biochem
– volume: 119
  start-page: 1420
  issue: 6
  year: 2009
  end-page: 1428
  ident: CR23
  article-title: The basics of epithelial-mesenchymal transition
  publication-title: J Clin Investig
– volume: 27
  start-page: 2411
  issue: 8
  year: 2019
  end-page: 2425
  ident: CR33
  article-title: Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies
  publication-title: Cell Rep
– volume: 70
  start-page: 6407
  issue: 16
  year: 2010
  end-page: 6411
  ident: CR9
  article-title: CD73: a novel target for cancer immunotherapy
  publication-title: Can Res
– volume: 117
  start-page: 4826
  issue: 18
  year: 2011
  end-page: 4835
  ident: CR7
  article-title: The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells
  publication-title: Blood
– volume: 33
  start-page: 4016
  issue: 30
  year: 2014
  end-page: 4020
  ident: CR14
  article-title: Tumor resident mesenchymal stromal cells endow naive stromal cells with tumor-promoting properties
  publication-title: Oncogene
– volume: 10
  start-page: 1412
  issue: 4
  year: 2018
  end-page: 1425
  ident: CR39
  article-title: CD73 regulates stemness and epithelial-mesenchymal transition in ovarian cancer-initiating cells
  publication-title: Stem Cell Rep
– volume: 70
  start-page: 203
  issue: 1
  year: 2018
  end-page: 213
  ident: CR50
  article-title: MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway
  publication-title: Cytotechnology
– volume: 39
  start-page: 1010428317695021
  issue: 3
  year: 2017
  ident: CR11
  article-title: Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
  publication-title: Tumor Biol
– volume: 34
  start-page: 1
  issue: 1
  year: 2015
  end-page: 15
  ident: CR17
  article-title: Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8
  publication-title: J Exp Clin Cancer Res
– volume: 65
  start-page: 1159
  issue: 10
  year: 2016
  end-page: 1167
  ident: CR43
  article-title: Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer
  publication-title: Cancer Immunol Immunother
– volume: 38
  start-page: 1
  issue: 1
  year: 2019
  end-page: 13
  ident: CR63
  article-title: Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway
  publication-title: J Exp Clin Cancer Res
– volume: 138
  start-page: 180
  issue: 2
  year: 2018
  end-page: 184
  ident: CR38
  article-title: CD73 expression in lymph node metastases in patients with head and neck cancer
  publication-title: Acta Otolaryngol
– volume: 16
  start-page: 35
  issue: 1
  year: 2017
  end-page: 52
  ident: CR13
  article-title: Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
  publication-title: Nat Rev Drug Discov
– volume: 4
  start-page: 261
  year: 2013
  ident: CR64
  article-title: The role of mesenchymal stem cells in cancer development
  publication-title: Fron Genet
– volume: 16
  start-page: 31
  issue: 1
  year: 2017
  ident: CR15
  article-title: Mesenchymal stem cells: key players in cancer progression
  publication-title: Mol cancer
– volume: 886
  start-page: 173509
  year: 2020
  ident: CR49
  article-title: The effect of oleuropein on apoptotic pathway regulators in breast cancer cells
  publication-title: Eur J Pharm
– year: 2017
  ident: CR2
  article-title: Mesenchymal stem and progenitor cells in regeneration: tissue specificity and regenerative potential
  publication-title: Stem Cells Int
  doi: 10.1155/2017/5173732
– volume: 39
  start-page: 3489
  issue: 17
  year: 2020
  end-page: 3506
  ident: CR60
  article-title: Capicua restricts cancer stem cell-like properties in breast cancer cells
  publication-title: Oncogene
– volume: 294
  start-page: 11213
  issue: 29
  year: 2019
  end-page: 11224
  ident: CR41
  article-title: Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells
  publication-title: J Biol Chem
– volume: 79
  start-page: 3360
  issue: 13
  year: 2019
  end-page: 3371
  ident: CR25
  article-title: Inflammatory breast cancer promotes development of M2 tumor-associated macrophages and cancer mesenchymal cells through a complex chemokine network
  publication-title: Can Res
– volume: 33
  start-page: 652
  year: 2020
  end-page: 662
  ident: CR31
  article-title: Gastric-cancer-derived mesenchymal stem cells: a promising target for resveratrol in the suppression of gastric cancer metastasis
  publication-title: Hum Cell
– volume: 19
  start-page: 660
  issue: 5
  year: 2017
  end-page: 668
  ident: CR19
  article-title: Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival
  publication-title: Neuro-oncology
– volume: 7
  start-page: 139
  issue: 2
  year: 2007
  end-page: 147
  ident: CR1
  article-title: The tumour microenvironment as a target for chemoprevention
  publication-title: Nat Rev Cancer
– volume: 5
  start-page: 95
  issue: 4
  year: 2014
  ident: CR18
  article-title: The bidirectional tumor-mesenchymal stromal cell interaction promotes the progression of head and neck cancer
  publication-title: Stem Cell Res Ther
– volume: 31
  start-page: 1980
  issue: 9
  year: 2013
  end-page: 1991
  ident: CR6
  article-title: Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages
  publication-title: Stem Cells
– volume: 9
  start-page: 539
  issue: 4
  year: 2019
  ident: CR28
  article-title: Bidirectional and opposite effects of naïve mesenchymal stem cells on tumor growth and progression
  publication-title: Adv Pharm Bull
– volume: 2
  start-page: 442
  issue: 6
  year: 2002
  end-page: 454
  ident: CR22
  article-title: Epithelial–mesenchymal transitions in tumour progression
  publication-title: Nat Rev Cancer
– volume: 19
  start-page: e23
  issue: 4
  year: 2019
  ident: CR51
  article-title: Adenosine blockage in tumor microenvironment and improvement of cancer immunotherapy
  publication-title: Immune Netw
– volume: 19
  start-page: 355
  issue: 6
  year: 2013
  end-page: 367
  ident: CR44
  article-title: CD39 and CD73 in immunity and inflammation
  publication-title: Trends in Mol Med
– volume: 42
  start-page: 2242
  issue: 6
  year: 2017
  end-page: 2254
  ident: CR20
  article-title: Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth through hedgehog signaling pathway
  publication-title: Cell Physiol Biochem
– year: 2019
  ident: CR4
  article-title: Enhancing mesenchymal stromal cell immunomodulation for treating conditions influenced by the immune system
  publication-title: Stem cells Int
  doi: 10.1155/2019/7219297
– volume: 107
  start-page: 1547
  issue: 4
  year: 2010
  end-page: 1552
  ident: CR32
  article-title: Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
  publication-title: Proc Natl Acad Sci
– volume: 11
  start-page: 3605
  year: 1864
  end-page: 3617
  ident: CR62
  article-title: (2018) Role of p38γ MAPK in regulation of EMT and cancer stem cells
  publication-title: Biochimica et Biophysica Acta (BBA)-Mol Basis Dis
– volume: 15
  start-page: 2123
  issue: 2
  year: 2018
  end-page: 2130
  ident: CR37
  article-title: Immunohistochemical CD73 expression status in gastrointestinal neuroendocrine neoplasms: a retrospective study of 136 patients
  publication-title: Oncol Lett
– volume: 4
  start-page: 879
  issue: 8
  year: 2014
  end-page: 888
  ident: CR10
  article-title: Targeting cancer-derived adenosine: new therapeutic approaches
  publication-title: Cancer Discov
– volume: 115
  start-page: E1239
  issue: 6
  year: 2018
  end-page: E1248
  ident: CR58
  article-title: Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells
  publication-title: Proc Natl Acad Sci
– volume: 10
  start-page: 117
  issue: 1
  year: 2019
  ident: CR21
  article-title: Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway
  publication-title: Stem Cell Res Ther
– volume: 25
  start-page: 1
  issue: 1
  year: 2018
  end-page: 18
  ident: CR59
  article-title: Cancer stem cells as key drivers of tumour progression
  publication-title: J Biomed Sci
– volume: 68
  start-page: 493
  issue: 4
  year: 1996
  end-page: 500
  ident: CR46
  article-title: Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance
  publication-title: Int J Cancer
– volume: 35
  start-page: 766
  issue: 3
  year: 2017
  end-page: 776
  ident: CR8
  article-title: Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression
  publication-title: Stem cells
– volume: 15
  start-page: 366
  issue: 6
  year: 2018
  end-page: 381
  ident: CR30
  article-title: Targeting the tumour stroma to improve cancer therapy
  publication-title: Nat Rev Clin Oncol
– volume: 17
  start-page: 702
  issue: 6
  year: 2018
  end-page: 711
  ident: CR61
  article-title: The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer
  publication-title: Cell Cycle
– volume: 8
  start-page: 886
  issue: 8
  year: 2019
  ident: CR3
  article-title: Mesenchymal stem cells for regenerative medicine
  publication-title: Cells
– volume: 41
  start-page: 182
  issue: 2
  year: 2020
  end-page: 193
  ident: CR24
  article-title: The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression
  publication-title: Carcinogenesis
– volume: 449
  start-page: 557
  issue: 7162
  year: 2007
  end-page: 563
  ident: CR12
  article-title: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
  publication-title: Nature
– volume: 26
  start-page: 2112
  issue: 9
  year: 2011
  end-page: 2124
  ident: CR53
  article-title: Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes
  publication-title: J Bone Miner Res
– volume: 18
  start-page: 1
  issue: 1
  year: 2018
  end-page: 10
  ident: CR40
  article-title: Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
  publication-title: BMC cancer
– volume: 37
  start-page: 8403
  issue: 6
  year: 2016
  end-page: 8412
  ident: CR52
  article-title: Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles
  publication-title: Tumor Biol
– volume: 98
  start-page: 1591
  issue: 3
  year: 2018
  end-page: 1625
  ident: CR35
  article-title: Pharmacology of adenosine receptors: the state of the art
  publication-title: Physiol Rev
– volume: 20
  start-page: 1221
  issue: 8
  year: 2011
  end-page: 1230
  ident: CR54
  article-title: Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation
  publication-title: Cell Transpl
– volume: 18
  start-page: 669
  issue: 11
  year: 2018
  end-page: 680
  ident: CR26
  article-title: Stem cell fate in cancer growth, progression and therapy resistance
  publication-title: Nat Rev Cancer
– volume: 185
  start-page: 1132
  issue: 4
  year: 2018
  ident: 674_CR47
  publication-title: Appl Biochem Biotechnol
  doi: 10.1007/s12010-017-2684-0
– volume: 41
  start-page: 182
  issue: 2
  year: 2020
  ident: 674_CR24
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgz083
– volume: 28
  start-page: 477
  issue: 7
  year: 2019
  ident: 674_CR57
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2018.0183
– volume: 39
  start-page: 3489
  issue: 17
  year: 2020
  ident: 674_CR60
  publication-title: Oncogene
  doi: 10.1038/s41388-020-1230-7
– volume: 108
  start-page: 1939
  issue: 10
  year: 2017
  ident: 674_CR29
  publication-title: Cancer Sci
  doi: 10.1111/cas.13334
– volume: 15
  start-page: 366
  issue: 6
  year: 2018
  ident: 674_CR30
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-018-0007-1
– volume: 10
  start-page: 1412
  issue: 4
  year: 2018
  ident: 674_CR39
  publication-title: Stem Cell Rep
  doi: 10.1016/j.stemcr.2018.02.009
– volume: 18
  start-page: 1
  issue: 1
  year: 2018
  ident: 674_CR40
  publication-title: BMC cancer
  doi: 10.1186/s12885-017-3892-2
– volume: 6
  start-page: e1320011
  issue: 6
  year: 2017
  ident: 674_CR42
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2017.1320011
– volume: 33
  start-page: 4016
  issue: 30
  year: 2014
  ident: 674_CR14
  publication-title: Oncogene
  doi: 10.1038/onc.2013.387
– volume: 119
  start-page: 1173
  issue: 10
  year: 2015
  ident: 674_CR34
  publication-title: J Appl Physiol
  doi: 10.1152/japplphysiol.00350.2015
– volume: 19
  start-page: 355
  issue: 6
  year: 2013
  ident: 674_CR44
  publication-title: Trends in Mol Med
  doi: 10.1016/j.molmed.2013.03.005
– volume: 37
  start-page: 8403
  issue: 6
  year: 2016
  ident: 674_CR52
  publication-title: Tumor Biol
  doi: 10.1007/s13277-015-4732-0
– volume: 107
  start-page: 1547
  issue: 4
  year: 2010
  ident: 674_CR32
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.0908801107
– volume: 79
  start-page: 3360
  issue: 13
  year: 2019
  ident: 674_CR25
  publication-title: Can Res
  doi: 10.1158/0008-5472.CAN-17-2158
– volume: 11
  start-page: 3605
  year: 1864
  ident: 674_CR62
  publication-title: Biochimica et Biophysica Acta (BBA)-Mol Basis Dis
– year: 2019
  ident: 674_CR4
  publication-title: Stem cells Int
  doi: 10.1155/2019/7219297
– volume: 115
  start-page: E1239
  issue: 6
  year: 2018
  ident: 674_CR58
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.1718197115
– volume: 10
  start-page: 1729
  year: 2019
  ident: 674_CR45
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01729
– volume: 25
  start-page: 337
  issue: 4
  year: 2016
  ident: 674_CR56
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2015.0227
– volume: 79
  start-page: 5200
  issue: 13 Supplement
  year: 2019
  ident: 674_CR36
  publication-title: Cancer Res.
  doi: 10.1158/1538-7445.AM2019-5200
– volume: 8
  start-page: 886
  issue: 8
  year: 2019
  ident: 674_CR3
  publication-title: Cells
  doi: 10.3390/cells8080886
– volume: 7
  start-page: 66
  issue: 1
  year: 2011
  ident: 674_CR55
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2011.04.001
– volume: 7
  start-page: 139
  issue: 2
  year: 2007
  ident: 674_CR1
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2067
– volume: 26
  start-page: 2112
  issue: 9
  year: 2011
  ident: 674_CR53
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.424
– volume: 19
  start-page: e23
  issue: 4
  year: 2019
  ident: 674_CR51
  publication-title: Immune Netw
  doi: 10.4110/in.2019.19.e23
– volume: 38
  start-page: 1
  issue: 1
  year: 2019
  ident: 674_CR63
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-1018-6
– volume: 5
  start-page: 95
  issue: 4
  year: 2014
  ident: 674_CR18
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt484
– volume: 8
  start-page: 97
  issue: 2
  year: 2011
  ident: 674_CR27
  publication-title: Nat Rev Clin oncol
  doi: 10.1038/nrclinonc.2010.196
– volume: 4
  start-page: 879
  issue: 8
  year: 2014
  ident: 674_CR10
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-14-0341
– volume: 26
  start-page: 799
  issue: 6
  year: 2010
  ident: 674_CR65
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000323973
– volume: 886
  start-page: 173509
  year: 2020
  ident: 674_CR49
  publication-title: Eur J Pharm
  doi: 10.1016/j.ejphar.2020.173509
– volume: 2
  start-page: 442
  issue: 6
  year: 2002
  ident: 674_CR22
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc822
– volume: 449
  start-page: 557
  issue: 7162
  year: 2007
  ident: 674_CR12
  publication-title: Nature
  doi: 10.1038/nature06188
– volume: 117
  start-page: 4826
  issue: 18
  year: 2011
  ident: 674_CR7
  publication-title: Blood
  doi: 10.1182/blood-2010-12-324038
– volume: 42
  start-page: 2242
  issue: 6
  year: 2017
  ident: 674_CR20
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000479998
– volume: 35
  start-page: 766
  issue: 3
  year: 2017
  ident: 674_CR8
  publication-title: Stem cells
  doi: 10.1002/stem.2509
– volume: 4
  start-page: 41
  issue: 4
  year: 2016
  ident: 674_CR5
  publication-title: Vaccines
  doi: 10.3390/vaccines4040041
– volume: 39
  start-page: 101042831769502
  issue: 3
  year: 2017
  ident: 674_CR11
  publication-title: Tumor Biol
  doi: 10.1177/1010428317695021
– volume: 27
  start-page: 2411
  issue: 8
  year: 2019
  ident: 674_CR33
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2019.04.091
– volume: 18
  start-page: 669
  issue: 11
  year: 2018
  ident: 674_CR26
  publication-title: Nat Rev Cancer
  doi: 10.1038/s41568-018-0056-x
– volume: 4
  start-page: 261
  year: 2013
  ident: 674_CR64
  publication-title: Fron Genet
– volume: 20
  start-page: 1221
  issue: 8
  year: 2011
  ident: 674_CR54
  publication-title: Cell Transpl
  doi: 10.3727/096368910X546553
– volume: 16
  start-page: 35
  issue: 1
  year: 2017
  ident: 674_CR13
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2016.193
– volume: 16
  start-page: 31
  issue: 1
  year: 2017
  ident: 674_CR15
  publication-title: Mol cancer
  doi: 10.1186/s12943-017-0597-8
– volume: 79
  start-page: 320
  issue: 3
  year: 2019
  ident: 674_CR16
  publication-title: Prostate
  doi: 10.1002/pros.23738
– volume: 17
  start-page: 702
  issue: 6
  year: 2018
  ident: 674_CR61
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2018.1450029
– volume: 34
  start-page: 1
  issue: 1
  year: 2015
  ident: 674_CR17
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-014-0119-0
– volume: 294
  start-page: 11213
  issue: 29
  year: 2019
  ident: 674_CR41
  publication-title: J Biol Chem
  doi: 10.1074/jbc.RA118.006889
– volume: 9
  start-page: 539
  issue: 4
  year: 2019
  ident: 674_CR28
  publication-title: Adv Pharm Bull
  doi: 10.15171/apb.2019.063
– volume: 33
  start-page: 652
  year: 2020
  ident: 674_CR31
  publication-title: Hum Cell
  doi: 10.1007/s13577-020-00339-5
– volume: 70
  start-page: 203
  issue: 1
  year: 2018
  ident: 674_CR50
  publication-title: Cytotechnology
  doi: 10.1007/s10616-017-0134-z
– volume: 31
  start-page: 1980
  issue: 9
  year: 2013
  ident: 674_CR6
  publication-title: Stem Cells
  doi: 10.1002/stem.1432
– volume: 65
  start-page: 1159
  issue: 10
  year: 2016
  ident: 674_CR43
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-016-1879-5
– volume: 119
  start-page: 7905
  issue: 10
  year: 2018
  ident: 674_CR48
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.27091
– volume: 15
  start-page: 2123
  issue: 2
  year: 2018
  ident: 674_CR37
  publication-title: Oncol Lett
– volume: 70
  start-page: 6407
  issue: 16
  year: 2010
  ident: 674_CR9
  publication-title: Can Res
  doi: 10.1158/0008-5472.CAN-10-1544
– volume: 138
  start-page: 180
  issue: 2
  year: 2018
  ident: 674_CR38
  publication-title: Acta Otolaryngol
  doi: 10.1080/00016489.2017.1378436
– volume: 10
  start-page: 117
  issue: 1
  year: 2019
  ident: 674_CR21
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-019-1220-2
– volume: 119
  start-page: 1420
  issue: 6
  year: 2009
  ident: 674_CR23
  publication-title: J Clin Investig
  doi: 10.1172/JCI39104
– volume: 25
  start-page: 1
  issue: 1
  year: 2018
  ident: 674_CR59
  publication-title: J Biomed Sci
  doi: 10.1186/s12929-017-0402-4
– volume: 19
  start-page: 660
  issue: 5
  year: 2017
  ident: 674_CR19
  publication-title: Neuro-oncology
– volume: 68
  start-page: 493
  issue: 4
  year: 1996
  ident: 674_CR46
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19961115)68:4<493::AID-IJC15>3.0.CO;2-6
– year: 2017
  ident: 674_CR2
  publication-title: Stem Cells Int
  doi: 10.1155/2017/5173732
– volume: 98
  start-page: 1591
  issue: 3
  year: 2018
  ident: 674_CR35
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00049.2017
SSID ssj0015830
Score 2.3043914
SecondaryResourceType review_article
Snippet The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and...
The development of new therapies based on tumor biology is one of the main topics in cancer treatment. In this regard, investigating the microenvironment and...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 205
SubjectTerms Adenosine
Apoptosis
Cancer
Cancer therapies
CD4 antigen
Cell activation
Cell proliferation
Hematology
Immune system
Immunological tolerance
Inflammation
Internal Medicine
Lymphocytes T
Medicine
Medicine & Public Health
Mesenchymal stem cells
Microenvironments
Oncology
PD-1 protein
PD-L1 protein
Phenotypes
Prostaglandin E2
Review Article
Stem cells
Tryptophan 2,3-dioxygenase
Title Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment
URI https://link.springer.com/article/10.1007/s10238-020-00674-9
https://www.ncbi.nlm.nih.gov/pubmed/33484380
https://www.proquest.com/docview/2514711841
https://www.proquest.com/docview/2480336839
Volume 21
WOSCitedRecordID wos000610477500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1591-9528
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0015830
  issn: 1591-8890
  databaseCode: RSV
  dateStart: 20010106
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9xADLYKRagXKM8G6GqQuMFIeU0yOaKqiANdVby0t2jimYhK3Yd2s5X677GzSQDxkEDKbSYzke0Z27H9GeAoDJ0rMmVlRiyQcZkV0qDyJSlznYY6scbWnL5I-309GGS_m6KwWZvt3oYk65v6UbEbqRfJ7g5fsbHMluAzqTvNx_Hy6raLHShddxghPR1IrTO_KZV5eY2n6uiZjfksPlqrnbP1j33wV1hrzExxupCLDfjkRpuw-qsJpG-BvZ4Px1NJvjY3Fa2EsQwaTkNyUkPA0j5iyIVJePd_SAsx3LPgn_wzYegRk3HFaUY0skglF2T7CmQJmooud30bbs5-Xv84l03DBYlRqioZYWwiY8sATenIk0qNzlLH8DWYWDQBhmGQFLpg0D6LvrMlluROJbEJS2tSjHZgeTQeuW8g0EdUUUKaoFQxXaFaWe2TKWacCgsXKw-Clu45Nmjk3BTjb_6Ao8zky4l8eU2-PPPguHtnssDieHP2QcvOvDmXs5ysOdLG5NUGHhx2w3SimIJm5MZzmhNrP4oSshw92F2IQbcd1y0zRr8HJy3PHxZ__Vv23jd9H76EnDpT51UewHI1nbvvsIL_qj-zaQ-W0oHu1TJ_D_cQ-fA
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9wwDLfYMY29APuAFRhk0t62SP1Kmz5O0xBoxwnBDfFWpU4qJnEfuush8d_P7rVlEx8Sk_qWNKlsJ7Zr-2eAz2HoXJEpKzNigYzLrJAGlS9Jmes01Ik1tuZ0Px0M9OVldtoUhc3bbPc2JFnf1H8Vu5F6kezu8BUby-wFrMaksTiR7-z8oosdKF13GCE9HUitM78plXl4jX_V0T0b8158tFY7hxv_98GbsN6YmeLbUi7ewIobv4VXJ00g_R3Y4WI0mUnytbmpaCWMZdBwGpLTGgKW9hEjLkzCq9sRLcRwz4J_8s-FoUdMJxWnGdHIMpVckO0rkCVoJrrc9ffw6_DH8PuRbBouSIxSVckIYxMZWwZoSkeeVGp0ljqGr8HEogkwDIOk0AWD9ln0nS2xJHcqiU1YWpNitAW98WTsPoBAH1FFCWmCUsV0hWpltU-mmHEqLFysPAhauufYoJFzU4zr_A5HmcmXE_nymnx55sGX7p3pEovjydl7LTvz5lzOc7LmSBuTVxt48KkbphPFFDRjN1nQnFj7UZSQ5ejB9lIMuu24bpkx-j342vL8bvHHv2XnedMPYO1oeNLP-8eDn7vwOuQ0mjrHcg961WzhPsJLvKl-z2f7teT_AdLi--w
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9wwDLcGmxAv7BMoYxCkvW0R_UqbPiK20xDshASbeKtSJxVIXO9010Piv8duewXENmlC6lvSNLKd2K7tnwE-h6FzRaaszIgFMi6zQhpUviRlrtNQJ9bYhtMn6XCoLy6y0wdV_E22-yIk2dY0MEpTVe9PbLn_oPCNVI1k14ev21hmS_Ay5qZB7K-f_e7jCEo33UZIZwdS68zvymb-vMZj1fTE3nwSK21U0OD18zf_BtY681MctPLyFl646h2s_OwC7O_Bns9H46kkH5ybjdbCWAYTpyE5aaBh6ZtixAVLeHk7ooUYBlrwz_-ZMPSIyZg3QjIt2hRzQTaxQJasqehz2j_Ar8H388MfsmvEIDFKVS0jjE1kbBmgKR15WKnRWeoY1gYTiybAMAySQhcM5mfRd7bEktysJDZhaU2K0TosV-PKbYJAH1FFCWmIUsV0tWpltU8mmnEqLFysPAgWPMixQynnZhnX-T2-MpMvJ_LlDfnyzIMv_TuTFqPjn7O3F6zNu_M6y8nKIy1N3m7gwV4_TCeNKWgqN57TnFj7UZSQRenBRisS_ee4npmx-z34uuD__eJ_38vW_03fhZXTb4P85Gh4_BFWQ86uaVIvt2G5ns7dJ3iFN_XVbLrTHII7EoUE3w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor-resident+adenosine-producing+mesenchymal+stem+cells+as+a+potential+target+for+cancer+treatment&rft.jtitle=Clinical+and+experimental+medicine&rft.au=Arab%2C+Samaneh&rft.au=Alizadeh%2C+Akram&rft.au=Asgharzade%2C+Samira&rft.date=2021-05-01&rft.issn=1591-8890&rft.eissn=1591-9528&rft.volume=21&rft.issue=2&rft.spage=205&rft.epage=213&rft_id=info:doi/10.1007%2Fs10238-020-00674-9&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10238_020_00674_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1591-8890&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1591-8890&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1591-8890&client=summon